SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Importance of Economic Evaluation in Health Care: An Indian Perspective
15 references·1 citing·43 second hop
Importance of Economic Evaluation in Health Care: An Indian Perspective (2016)Importance of Economic Evaluation in Heal…Cost-Effectiveness in Health and Medicine (2016)Cost-Effectiveness in Health …International Network of Agencies for Health Technology Assessment (2014)International Network of Agen…Essentials of Pharmacoeconomics (2013)Essentials of Pharmacoeconomi…Priority-Setting Institutions in Health: Recommendations from a Center for Global Development Working Group (2012)Priority-Setting Institutions…The role of health technology assessment on pharmaceutical reimbursement in selected middle-income countries (2010)The role of health technology…Quantifying the Impoverishing Effects of Purchasing Medicines: A Cross-Country Comparison of the Affordability of Medicines in the Developing World (2010)Quantifying the Impoverishing…Outcome Measurement in Economic Evaluations of Public Health Interventions: a Role for the Capability Approach? (2010)Outcome Measurement in Econom…Historical development of health technology assessment in Thailand (2009)Historical development of hea…Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis (2008)Medicine prices, availability…The Value of Implementation and the Value of Information: Combined and Uneven Development (2007)The Value of Implementation a…Better Health Systems for India's Poor : Findings, Analysis, and Options (2002)Better Health Systems for Ind…Cost-Effectiveness in Health and Medicine (1996)Cost-Effectiveness in Health …Markov Models in Medical Decision Making (1993)Markov Models in Medical Deci…Utilities and Quality-Adjusted Life Years (1989)Utilities and Quality-Adjuste…Incorporating utility-based quality-of-life assessment measures in clinical trials. Two examples. (1989)Incorporating utility-based q…Measurement Instruments of Productivity Loss of Paid and Unpaid Work: A Systematic Review and Assessment of Suitability for Health Economic Evaluations From a Societal Perspective (2021)Measurement Instruments of Pr…The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. (1992)The MOS 36-ltem Short-Form Health Survey (SF-36) (1992)An investigation of the construct validity of the ICECAP-A capability measure (2012)VALUING THE ECONOMIC BENEFITS OF COMPLEX INTERVENTIONS: WHEN MAXIMISING HEALTH IS NOT SUFFICIENT (2012)Applications of the Capability Approach in the Health Field: A Literature Review (2016)Games and Decisions: Introduction and Critical Survey. (1958)Social preferences for health states: An empirical evaluation of three measurement techniques (1976)Assessing responsiveness of generic and specific health related quality of life measures in heart failure (2006)Utilities and disutilities for attributes of injectable treatments for type 2 diabetes (2010)Preferences of Heart Failure Patients in Daily Clinical Practice: Quality of Life or Longevity? (2013)Theory of games and economic behavior (2019)Decisions with Multiple Objectives: Preferences and Value Tradeoffs. (1994)Multi-Attribute Preference Functions (1995)A Comparative Review of Generic Quality-of-Life Instruments (2000)The Health Utilities Index (HUI®) system for assessing health-related quality of life in clinical studies (2001)Methods for the Economic Evaluation of Health Care Programmes (2005)Applied Statistical Decision Theory (1962)Net Health Benefits (1998)Representing uncertainty: the role of cost‐effectiveness acceptability curves (2001)Value of Information and Value of Implementation: Application of an Analytic Framework to Inform Resource Allocation Decisions in Metastatic Hormone-Refractory Prostate Cancer (2008)Informing a decision framework for when NICE should recommend the use of health technologies only in the context of an appropriately designed programme of evidence development (2012)The economic case for precision medicine (2018)Human Development Report (2001)Analyzing Health Equity Using Household Survey Data: A Guide to Techniques and Their Implementation (2007)A win-win solution?: A critical analysis of tiered pricing to improve access to medicines in developing countries (2011)Universal Declaration of Human Rights (2011)The Availability, Pricing and Affordability of Three Essential Asthma Medicines in 52 Low- and Middle-Income Countries (2013)Revisiting the issue of access to medicines in Africa: Challenges and recommendations (2022)EQ-SD: a measure of health status from the EuroQol Group (2001)Innovation in the pharmaceutical industry: New estimates of R&D costs (2016)Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses (2016)Preventing impoverishment through protection against catastrophic health expenditure. (2002)Deepening health insecurity in India: evidence from National Sample Surveys since 1980s. (2009)Inequities in Access to Health Services in India: Caste, Class and Region (2010)THE WORLD MEDICINES SITUATION 2011 (2011)The Economic Costs of Type 2 Diabetes: A Global Systematic Review (2015)Essential medicines for universal health coverage (2016)An Introduction to Markov Modelling for Economic Evaluation (1998)Handling Uncertainty in Cost-Effectiveness Models (2000)Review of guidelines for good practice in decision-analytic modelling in health technology assessment (2004)Cost-Effectiveness Analysis Alongside Clinical Trials II—An ISPOR Good Research Practices Task Force Report (2015)Defining Elements of Value in Health Care—A Health Economics Approach: An ISPOR Special Task Force Report [3] (2018)Simulating the Potential Impacts of COVID-19 School Closures on Schooling and Learning Outcomes: A Set of Global Estimates (2020)
this work references cited by second hop

References

  • 1996Cost-Effectiveness in Health and Medicine7,192 cited
  • 1993Markov Models in Medical Decision Making2,411 cited
  • 2016Cost-Effectiveness in Health and Medicine1,550 cited
  • 2008Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis926 cited
  • 1989Utilities and Quality-Adjusted Life Years819 cited
  • 2002Better Health Systems for India's Poor : Findings, Analysis, and Options267 cited
  • 2007The Value of Implementation and the Value of Information: Combined and Uneven Development173 cited
  • 2010Quantifying the Impoverishing Effects of Purchasing Medicines: A Cross-Country Comparison of the Affordability of Medicines in the Developing World168 cited
  • 1989Incorporating utility-based quality-of-life assessment measures in clinical trials. Two examples.166 cited
  • 2010Outcome Measurement in Economic Evaluations of Public Health Interventions: a Role for the Capability Approach?135 cited
  • 2013Essentials of Pharmacoeconomics117 cited
  • 2014International Network of Agencies for Health Technology Assessment99 cited
  • 2012Priority-Setting Institutions in Health: Recommendations from a Center for Global Development Working Group98 cited
  • 2010The role of health technology assessment on pharmaceutical reimbursement in selected middle-income countries

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

97 cited
  • 2009Historical development of health technology assessment in Thailand72 cited
  • Cited by

    • 2021Measurement Instruments of Productivity Loss of Paid and Unpaid Work: A Systematic Review and Assessment of Suitability for Health Economic Evaluations From a Societal Perspective61 cited